Nanoparticles in Angiogenesis and Cancer (Record no. 85911)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03155nam a22005775i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-3-031-11284-3 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240730164815.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220927s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| ISBN | 9783031112843 |
| -- | 978-3-031-11284-3 |
| 082 04 - CLASSIFICATION NUMBER | |
| Call Number | 620,115 |
| 100 1# - AUTHOR NAME | |
| Author | Mukherjee, Sudip. |
| 245 10 - TITLE STATEMENT | |
| Title | Nanoparticles in Angiogenesis and Cancer |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. 2022. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | VIII, 82 p. 27 illus., 10 illus. in color. |
| 490 1# - SERIES STATEMENT | |
| Series statement | Synthesis Lectures on Biomedical Engineering, |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Remark 2 | Chapter 1 - Introduction -- Chapter 2 - Current Anti-angiogenic Therapies and their Limitations -- Chapter 3 - Nanomedicine -- Chapter 4 - Organic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 5 - Inorganic Nanoparticles in Anti-angiogenic Cancer Therapy -- Chapter 6 - Potential Challenges in Anti-angiogenic Nanotherapies -- Chapter 7 - Conclusion. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | This book highlights recent developments of organic and inorganic nanomedicine that play a major role in anti-angiogenic cancer therapy. In addition, the authors present examples of nanomedicine based anti-angiogenic agents and their applications in cancer therapy. Angiogenesis is a pathophysiological phenomenon that modulates cell proliferation and cell migration and plays important roles in cancer. Anti-angiogenic nanotherapies have gained immense attention in recent times as alternative cost-effective therapies that opened a new dimension in cancer theranostics. Further the challenges of the anti-angiogenic nanotherapies and possible future perspective are detailed. |
| 650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| General subdivision | Growth. |
| 700 1# - AUTHOR 2 | |
| Author 2 | Madamsetty, Vijay Sagar. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | https://doi.org/10.1007/978-3-031-11284-3 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | eBooks |
| 264 #1 - | |
| -- | Cham : |
| -- | Springer International Publishing : |
| -- | Imprint: Springer, |
| -- | 2022. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Nanomedicine. |
| 650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Nanotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Blood-vessels |
| 650 14 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Nanomedicine and Nanotoxicology. |
| 650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Impact of Nanotechnology. |
| 650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Cancer Nanotechnology. |
| 650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
| -- | Angiogenesis. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| -- | 1930-0336 |
| 912 ## - | |
| -- | ZDB-2-SXSC |
No items available.